Investigations on ALS: to adjust “protangleins”, could you put the right tool out of the “pocket”?
Medicomunicare Magazine | Health and Medical News
ALS, also known as Lou Gehrig’s disease, affects over 100,000 people worldwide. Currently, there are no effective treatments, largely due to a poor understanding of how the disease begins and progresses at the molecular level, so it is invariably fatal. Among the pivotal cellular phenomena, the researchers noted that the motor neurons of ALS patients